caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871576199

Ilana CassM.D.

Gynecological OncologyLebanon, NHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
145
Beneficiaries
—
Total drug cost
$280K
Distinct drugs
8
Brand share
27.6%
Top prescribed drugs
Prochlorperazine Maleate30 claims
Olaparib22 claims
Dexamethasone21 claims
Lidocaine/Prilocaine18 claims
Ondansetron Hcl18 claims
REFERRAL NETWORK

Where Ilana Cass's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BARBUTO, DENISE29120
Unilab Corporation
Clinical Laboratory · West Hills, CA
2078
Cindy Kallman
Diagnostic Radiology · Los Angeles, CA
1357
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
245
Unique beneficiaries
—
Total services
346
Distinct HCPCS
9
Medicare payment
$48K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3 Gynecological Oncology providers in NH — above median (cohort median 453).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.